Michael F Borah, MD
Internal Medicine · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Office
- 1
- Since medical school
- 55 years
- New York University School of Medicine, 1971
Offices
1 location · Renal Medical Associates · 6 clinicians in this group
Looking this up.
Hospitals listed: 052719 · 552811 · 552888 · California Pacific Medical Center - Mission Bernal · California Pacific Medical Center- Van Ness Campus · California Pacific Medical Ctr-Davies Campus Hosp · Stanford Health Care · UCSF Medical Center. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Borah’s office at (415) 923-3456 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence G20356 · Current
Licensed to practise in California · since 1971 · expires 2028-10-31 · New York University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Internal Medicine
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 92.8 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Hospitals they work in
5 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- California Pacific Medical Center - Mission BernalSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Church · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.322, Oct 2024 – Sep 2025
- California Pacific Medical Center- Van Ness CampusSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.224, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.325, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.373, Oct 2024 – Sep 2025
- California Pacific Medical Ctr-Davies Campus HospSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · No emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.187, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
- UCSF Medical CenterSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of UCSF Helen Diller Family Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 4.9 (3.79 to 6.02) · 7,590 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.8 (11.3 to 14.4) · 2,019 cases, Jan 2024 – Dec 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 139.4 (110.22 to 168.58) · 452 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.622, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.626, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.491, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,336 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for California Pacific Medical Center - Mission Bernal
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 3 the same, 3 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.322 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.24 (0.19 to 2.28) · 336 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.47 to 1.27) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 163.19 (101.27 to 225.11) · 28 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.5 · 44 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.6 · 155 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.4 · 177 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.6 · 32 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 1,281 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.42) · 2,912 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.04 to 0.45) · 2,681 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.07 (1.81 to 6.33) · 787 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.61 (0 to 3.31) · 425 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.46 (0.79 to 4.12) · 755 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.36 (0 to 16.38) · 431 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.47 (1.38 to 9.55) · 401 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.7 (0.2 to 3.2) · 105 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 1.16) · 2,291 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 2.4 · 369 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.602 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.618 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 242 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 20.9 · 197 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 39.6 · 203 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 292 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.9 · 353 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.9 · 74 cases | None | Jul 2023 – Jun 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 110 cases | No different | Jan 2024 – Dec 2024 |
What patients said (406 patients answered, 18% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 74% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for California Pacific Medical Center- Van Ness Campus
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.224 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.325 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.373 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.14 (0.3 to 1.97) · 2,271 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.81 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.86 (151.51 to 234.22) · 140 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10.3 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.5 · 143 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.8 · 356 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.3 · 259 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 173 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,316 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.12 to 0.49) · 6,430 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.09 to 0.47) · 7,168 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.3 (1.5 to 5.09) · 2,196 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.47 (1.21 to 3.74) · 925 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.63 (1.37 to 3.88) · 1,954 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.13 (6.06 to 14.2) · 1,112 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.26 (4.67 to 9.85) · 1,084 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.31 to 3.03) · 832 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.33 (0 to 0.85) · 5,406 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0.443 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.717 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 200 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 449 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 18.2 · 187 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 8.7 · 418 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.1 · 260 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.2 · 293 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.6 to 7.6) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.2 (7.7 to 13.5) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 11 · 33 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 66 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.4 to 16.7) · 551 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.3) · 219 cases | No different | Jan 2024 – Dec 2024 |
What patients said (478 patients answered, 20% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for California Pacific Medical Ctr-Davies Campus Hosp
Behind the star rating — Deaths: 0 better, 4 the same, 0 worse of 4 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 4 the same, 1 worse of 5 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.187 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.02 (0 to 2.09) · 232 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.98 (0.56 to 1.4) | No different | Jul 2022 – Jun 2024 |
| Death rate for heart failure patientsComplications and deaths | 10 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.1 · 106 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.4 · 257 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 721 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.26 (0.03 to 0.49) · 2,031 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.45) · 2,032 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.35 (0.94 to 5.76) · 419 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.41 (0 to 3) · 211 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.84 (1.24 to 4.44) · 414 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.95 (2.91 to 20.98) · 218 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.61 (1.47 to 9.75) · 198 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.74 (0.22 to 3.26) · 52 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.32 (0 to 1.28) · 1,461 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.6 · 58 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.756 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 91 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 65.3 · 84 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -26.6 · 115 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.4 · 142 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.5 · 55 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 25 cases | None | Jul 2023 – Jun 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 312 cases | No different | Jan 2024 – Dec 2024 |
What patients said (602 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for UCSF Medical Center
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 3 better, 5 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.9 (3.79 to 6.02) · 7,590 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.8 (11.3 to 14.4) · 2,019 cases | Worse | Jan 2024 – Dec 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 139.4 (110.22 to 168.58) · 452 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.622 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.626 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.491 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 2,336 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.24 (0.58 to 1.9) · 4,689 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.89 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.5 · 85 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.1 · 132 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.6 · 454 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 618 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 380 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.7 · 5,000 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.06 to 0.38) · 15,965 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.05 to 0.35) · 17,859 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.85 (0 to 1.83) · 4,184 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2 (1.1 to 2.9) · 6,516 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.35 (4.49 to 10.21) · 3,989 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5 (3.22 to 6.77) · 4,087 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.95 (0.74 to 3.15) · 2,034 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.95 (0.63 to 1.28) · 15,431 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 399 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.899 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.689 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.224 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16 · 156 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20 · 564 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 60.3 · 160 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -9.7 · 550 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 44.1 · 660 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 667 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (4.8 to 6.7) · 2,019 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 421 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 107 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.9 (11.3 to 17.1) · 3,247 cases | No different | Jan 2022 – Dec 2024 |
What patients said (3,181 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$269,650
Medicare paid this office $269,650 for 436 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 171 | $79,873 | $113 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 20 | $55,521 | $345 |
| Return visit (30+ min) | 155 | $39,681 | $128 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 100 | $18,351 | $162 |
| New patient visit (60+ min) | 64 | $13,924 | $218 |
See all 12 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 171 | $79,873 | $113 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 20 | $55,521 | $345 |
| Return visit (30+ min) | 155 | $39,681 | $128 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 100 | $18,351 | $162 |
| New patient visit (60+ min) | 64 | $13,924 | $218 |
| Long return visit (40+ min) | 67 | $11,252 | $163 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 56 | $9,438 | $169 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 13 | $9,212 | $288 |
| Advance care planning, first 30 minutes | 62 | $6,227 | $99 |
| Short return visit (20+ min) | 22 | $2,150 | $90 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,890 | $76 |
| Manual urinalysis test with examination using microscope, non-automated | 89 | $390 | $4 |
Who their Medicare patients are
436 Original Medicare patients in 2024. Average age 75 · Under 65 11% · 85 and older 19% · Women 44% · Also on Medicaid 40% · Health risk score 3.70. Sicker patients than 9 in 10 peers; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 75% · Chronic kidney disease 75% · Diabetes 51% · Coronary heart disease 43% · Heart failure 43% · Atrial fibrillation 30% · Depression 26% · COPD 18% · Cancer 17% · Stroke 17% · Dementia 15%.
The office billed $412,685, Medicare allowed $333,271 and paid $269,650; for 3,531 services of 27 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 436 | 3,531 | 75 | 3.70 | $412,685 | $269,650 |
| 2023 | 343 | 1,846 | 75 | 3.28 | $314,695 | $192,914 |
| 2022 | 338 | 1,702 | 76 | 3.02 | $344,715 | $207,031 |
| 2021 | 306 | 1,507 | 75 | 3.50 | $300,020 | $189,864 |
| 2020 | 244 | 1,299 | 75 | 3.56 | $241,595 | $150,500 |
| 2019 | 306 | 1,607 | 75 | 3.85 | $314,785 | $197,412 |
| 2018 | 309 | 1,694 | 74 | 3.52 | $340,375 | $209,755 |
| 2017 | 336 | 2,145 | 73 | 3.72 | $335,450 | $205,196 |
| 2016 | 325 | 4,070 | 73 | 3.20 | $375,380 | $233,342 |
| 2015 | 321 | 4,826 | 72 | 3.66 | $373,206 | $229,725 |
| 2014 | 310 | 2,992 | 72 | 3.58 | $374,565 | $230,107 |
| 2013 | 298 | 3,198 | 71 | 3.39 | $377,850 | $224,222 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 123 | $51,910 | $107 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 16 | $38,010 | $325 |
| Return visit (30+ min) | 141 | $35,639 | $116 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 70 | $12,106 | $157 |
| New patient visit (60+ min) | 53 | $10,476 | $198 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 15 | $9,484 | $271 |
| Long return visit (40+ min) | 55 | $8,965 | $152 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 55 | $8,601 | $156 |
| Advance care planning, first 30 minutes | 55 | $5,220 | $95 |
| Short return visit (20+ min) | 21 | $1,818 | $76 |
| Manual urinalysis test with examination using microscope, non-automated | 79 | $339 | $4 |
2022: 11 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 23 | $51,337 | $325 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 133 | $50,820 | $90 |
| Return visit (30+ min) | 140 | $33,906 | $115 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 81 | $17,974 | $176 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 14 | $10,315 | $271 |
| Long return visit (40+ min) | 65 | $9,930 | $148 |
| New patient visit (60+ min) | 46 | $9,210 | $200 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 58 | $9,043 | $156 |
| Advance care planning, first 30 minutes | 58 | $5,610 | $97 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $890 | $64 |
| Manual urinalysis test with examination using microscope, non-automated | 64 | $290 | $4 |
2021: 11 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 23 | $50,558 | $322 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 119 | $45,524 | $92 |
| Return visit (30+ min) | 115 | $29,374 | $113 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 78 | $17,666 | $178 |
| Long return visit (40+ min) | 70 | $10,731 | $143 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 49 | $7,682 | $157 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 17 | $7,621 | $272 |
| Advance care planning, first 30 minutes | 57 | $5,440 | $94 |
| New patient visit (60+ min) | 25 | $4,917 | $197 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 33 | $485 | $14 |
| Manual urinalysis test with examination using microscope, non-automated | 33 | $145 | $4 |
2020: 11 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 22 | $58,632 | $265 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 75 | $24,788 | $95 |
| Return visit (30+ min) | 98 | $20,557 | $98 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 44 | $9,268 | $185 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 49 | $6,886 | $141 |
| Long return visit (40+ min) | 52 | $6,684 | $119 |
| New patient visit (60+ min) | 32 | $6,242 | $195 |
| Advance care planning, first 30 minutes | 48 | $4,777 | $100 |
| Telephone medical discussion with physician, 11-20 minutes | 30 | $2,644 | $68 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 37 | $589 | $15 |
| Manual urinalysis test with examination using microscope, non-automated | 36 | $148 | $4 |
2019: 12 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 26 | $54,014 | $258 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 118 | $51,215 | $93 |
| Return visit (30+ min) | 124 | $29,165 | $97 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 75 | $17,744 | $181 |
| Long return visit (40+ min) | 79 | $10,747 | $126 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 63 | $8,770 | $139 |
| Advance care planning, first 30 minutes | 66 | $6,232 | $94 |
| New patient visit (60+ min) | 28 | $5,140 | $184 |
| Hemodialysis procedure with physician evaluation | 17 | $1,315 | $66 |
| Short return visit (20+ min) | 13 | $920 | $66 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 45 | $722 | $16 |
| Manual urinalysis test with examination using microscope, non-automated | 33 | $138 | $4 |
2018: 12 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 29 | $68,330 | $254 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 114 | $45,208 | $92 |
| Return visit (30+ min) | 136 | $33,107 | $94 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 82 | $16,383 | $178 |
| Long return visit (40+ min) | 90 | $11,396 | $113 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 69 | $9,543 | $138 |
| New patient visit (60+ min) | 36 | $6,804 | $189 |
| Advance care planning, first 30 minutes | 67 | $6,347 | $93 |
| Hemodialysis procedure with physician evaluation | 20 | $1,479 | $64 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,358 | $65 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 49 | $790 | $15 |
| Manual urinalysis test with examination using microscope, non-automated | 51 | $213 | $4 |
2017: 16 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 25 | $63,054 | $256 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 110 | $38,082 | $93 |
| Return visit (30+ min) | 146 | $34,617 | $95 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 71 | $15,790 | $179 |
| Long return visit (40+ min) | 77 | $10,024 | $119 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 64 | $8,867 | $139 |
| New patient visit (60+ min) | 33 | $6,170 | $187 |
| Advance care planning, first 30 minutes | 53 | $4,757 | $90 |
| Hemodialysis procedure with physician evaluation | 30 | $2,181 | $64 |
| Short return visit (20+ min) | 23 | $1,369 | $55 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,339 | $122 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $969 | $65 |
| Administration of influenza virus vaccine | 24 | $777 | $32 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 44 | $750 | $16 |
| Influenza vaccine, quadrivalent, 0.5 ml dosage | 25 | $437 | $17 |
| Manual urinalysis test with examination using microscope, non-automated | 56 | $243 | $4 |
2016: 17 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 24 | $62,923 | $259 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 117 | $59,343 | $93 |
| Return visit (30+ min) | 149 | $37,639 | $95 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 66 | $13,787 | $181 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 65 | $9,082 | $140 |
| Long return visit (40+ min) | 68 | $8,154 | $115 |
| New patient visit (60+ min) | 34 | $5,919 | $174 |
| Advance care planning, first 30 minutes | 51 | $4,829 | $95 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 11 | $3,944 | $219 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,956 | $122 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 18 | $1,876 | $65 |
| Administration of influenza virus vaccine | 41 | $1,329 | $32 |
| Short return visit (20+ min) | 20 | $1,285 | $64 |
| Hemodialysis procedure with physician evaluation | 17 | $1,104 | $65 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 44 | $769 | $17 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) | 41 | $484 | $12 |
| Manual urinalysis test with examination using microscope, non-automated | 68 | $309 | $4 |
2015: 16 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 32 | $66,445 | $260 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 109 | $52,048 | $93 |
| Return visit (30+ min) | 146 | $39,120 | $94 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 72 | $15,482 | $182 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 70 | $9,829 | $140 |
| Long return visit (40+ min) | 46 | $6,143 | $123 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 12 | $5,691 | $219 |
| New patient visit (60+ min) | 22 | $4,058 | $184 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 22 | $2,281 | $65 |
| Hemodialysis procedure with physician evaluation | 26 | $1,878 | $65 |
| New patient visit (45+ min) | 14 | $1,767 | $126 |
| Administration of influenza virus vaccine | 46 | $1,496 | $33 |
| Short return visit (20+ min) | 21 | $1,213 | $55 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 52 | $889 | $16 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) | 45 | $531 | $12 |
| Manual urinalysis test with examination using microscope, non-automated | 50 | $219 | $4 |
2014: 18 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 36 | $76,849 | $258 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 105 | $43,904 | $93 |
| Return visit (30+ min) | 133 | $37,729 | $96 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 70 | $13,665 | $180 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 17 | $9,165 | $218 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 61 | $8,313 | $136 |
| Long return visit (40+ min) | 42 | $5,135 | $114 |
| New patient visit (60+ min) | 23 | $4,209 | $183 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $1,801 | $64 |
| Short return visit (20+ min) | 22 | $1,331 | $55 |
| Hemodialysis procedure with physician evaluation | 20 | $1,295 | $65 |
| Administration of influenza virus vaccine | 36 | $1,140 | $32 |
| Pneumococcal vaccine, 23-valent | 14 | $1,011 | $72 |
| Injection of drug or substance under skin or into muscle | 12 | $786 | $25 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 48 | $775 | $16 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) | 36 | $543 | $15 |
| Administration of pneumococcal vaccine | 13 | $412 | $32 |
| Manual urinalysis test with examination using microscope, non-automated | 47 | $203 | $4 |
2013: 18 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 38 | $83,694 | $254 |
| Return visit (30+ min) | 132 | $38,400 | $92 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 99 | $36,006 | $90 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 66 | $14,768 | $172 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 19 | $7,020 | $213 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 36 | $4,825 | $134 |
| Long return visit (40+ min) | 27 | $3,318 | $118 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 16 | $3,202 | $200 |
| Hemodialysis procedure with physician evaluation | 26 | $2,388 | $63 |
| New patient visit (60+ min) | 12 | $2,242 | $187 |
| Short return visit (20+ min) | 32 | $2,112 | $56 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,495 | $62 |
| Administration of influenza virus vaccine | 43 | $1,435 | $33 |
| Pneumococcal vaccine, 23-valent | 16 | $1,124 | $70 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 41 | $671 | $16 |
| Administration of pneumococcal vaccine | 16 | $522 | $33 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval) | 43 | $389 | $9 |
| Manual urinalysis test with examination using microscope, non-automated | 44 | $189 | $4 |
Medicaid work
$10,417 in 2024
Medicaid paid $10,417 for 166 billed services this clinician did in 2024, up to 14 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 166 | $10,417 |
| 2024 | 166 | 1 | 14 | $10,417 |
| 2023 | 136 | 1 | 17 | $14,811 |
| 2022 | 34 | 1 | 13 | $2,231 |
| 2020 | 42 | 1 | 16 | $1,788 |
| 2019 | 66 | 1 | 18 | $3,323 |
See the largest Medicaid services in earlier years
2023
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 136 | $14,811 |
2022
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 34 | $2,231 |
2020
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 42 | $1,788 |
2019
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 66 | $3,323 |
Drugs they prescribed that Part D paid
$549,149
Pharmacies billed $549,149 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 1% of their Part D prescriptions (17 of 2,807) in 2024. At or below the middle of the specialty; the typical internal medicine clinician is at 1%.
2,345 generic and fewer than 11 brand-name prescriptions · $549,149 in drug cost · 49 antibiotic prescriptions to 31 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Farxiga | 93 | $109,620 | $1,179 |
| Jardiance | 56 | $76,559 | $1,367 |
| Eliquis | 45 | $51,012 | $1,134 |
| Januvia | 20 | $32,886 | $1,644 |
| Procrit | 28 | $30,889 | $1,103 |
See all 57 drugs
| Farxiga | 93 | $109,620 | $1,179 |
| Jardiance | 56 | $76,559 | $1,367 |
| Eliquis | 45 | $51,012 | $1,134 |
| Januvia | 20 | $32,886 | $1,644 |
| Procrit | 28 | $30,889 | $1,103 |
| Lokelma | 17 | $23,759 | $1,398 |
| Tradjenta | 26 | $22,153 | $852 |
| Potassium Citrate Er | 55 | $16,045 | $292 |
| Veltassa | 14 | $15,674 | $1,120 |
| Trulicity | 11 | $12,528 | $1,139 |
| Repatha | 11 | $7,315 | $665 |
| Calcium Acetate | 73 | $7,048 | $97 |
| Sevelamer Carbonate | 12 | $5,097 | $425 |
| Epogen | 12 | $3,095 | $258 |
| Febuxostat | 15 | $2,449 | $163 |
| Metoprolol | 112 | $2,244 | $20 |
| Atorvastatin | 210 | $2,180 | $10 |
| Allopurinol | 131 | $1,774 | $14 |
| Colchicine | 22 | $1,517 | $69 |
| Losartan | 148 | $1,449 | $10 |
| Diltiazem 24hr Er (Cd) | 17 | $1,302 | $77 |
| Lisinopril | 116 | $1,104 | $10 |
| Furosemide | 155 | $972 | $6 |
| Potassium Chloride | 17 | $923 | $54 |
| Omeprazole | 52 | $861 | $17 |
| Amlodipine Besylate | 153 | $859 | $6 |
| Levothyroxine | 60 | $801 | $13 |
| Irbesartan | 11 | $662 | $60 |
| Rosuvastatin | 42 | $643 | $15 |
| Chlorthalidone | 33 | $632 | $19 |
| Gabapentin | 34 | $619 | $18 |
| Midodrine | 13 | $519 | $40 |
| Carvedilol | 73 | $514 | $7 |
| Metformin Hcl Er | 14 | $470 | $34 |
| Prednisone | 39 | $424 | $11 |
| Calcitriol | 13 | $422 | $32 |
| Hydralazine | 34 | $409 | $12 |
| Valsartan | 17 | $400 | $24 |
| Pantoprazole | 31 | $386 | $12 |
| Spironolactone | 23 | $357 | $16 |
| Famotidine | 12 | $350 | $29 |
| Acyclovir | 17 | $346 | $20 |
| Metformin | 22 | $338 | $15 |
| Glipizide | 15 | $314 | $21 |
| Zolpidem | 20 | $305 | $15 |
| Triamterene-Hydrochlorothiazid | 20 | $290 | $15 |
| Tamsulosin | 26 | $274 | $11 |
| Hydrocodone-Acetaminophen | 14 | $255 | $18 |
| Simvastatin | 26 | $239 | $9 |
| Hydrochlorothiazide | 66 | $228 | $3 |
| Alprazolam | 13 | $191 | $15 |
| Ondansetron | 14 | $162 | $12 |
| Escitalopram | 12 | $126 | $10 |
| Clonidine | 16 | $116 | $7 |
| Bumetanide | 11 | $108 | $10 |
| Metoprolol | 25 | $101 | $4 |
| Ciprofloxacin | 12 | $73 | $6 |
Year by year
| 2024 | 2,807 | 285 | 1% (17) | None | $549,149 |
| 2023 | 2,632 | 269 | 1% (34) | 15% | $477,358 |
| 2022 | 2,594 | 261 | 2% (39) | None | $312,302 |
| 2021 | 2,326 | 230 | 3% (57) | None | $251,491 |
| 2020 | 2,185 | 208 | 2% (32) | 21% | $283,668 |
| 2019 | 2,049 | 200 | 1% (29) | None | $230,255 |
| 2018 | 2,278 | 229 | 2% (42) | 16% | $268,953 |
| 2017 | 2,514 | 237 | 2% (48) | 18% | $364,169 |
| 2016 | 2,441 | 225 | 2% (53) | 19% | $372,595 |
| 2015 | 2,437 | 218 | 3% (64) | 21% | $331,518 |
| 2014 | 2,879 | 219 | 3% (71) | 23% | $322,990 |
| 2013 | 3,335 | 213 | 3% (89) | 22% | $290,715 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 46 drugs
| Farxiga | 83 | $112,397 | $1,354 |
| Eliquis | 33 | $44,306 | $1,343 |
| Procrit | 30 | $39,227 | $1,308 |
| Tradjenta | 28 | $39,094 | $1,396 |
| Jardiance | 27 | $38,106 | $1,411 |
| Januvia | 14 | $22,233 | $1,588 |
| Veltassa | 15 | $15,837 | $1,056 |
| Potassium Citrate Er | 47 | $14,607 | $311 |
| Victoza 3-Pak | 12 | $13,761 | $1,147 |
| Sevelamer Carbonate | 12 | $7,183 | $599 |
| Calcium Acetate | 47 | $6,205 | $132 |
| Metoprolol | 96 | $3,210 | $33 |
| Allopurinol | 149 | $2,800 | $19 |
| Losartan | 176 | $2,322 | $13 |
| Atorvastatin | 198 | $2,308 | $12 |
| Colchicine | 28 | $1,937 | $69 |
| Furosemide | 153 | $1,576 | $10 |
| Lisinopril | 104 | $1,516 | $15 |
| Diltiazem 24hr Er (Cd) | 15 | $1,460 | $97 |
| Amlodipine Besylate | 153 | $1,447 | $9 |
| Calcitriol | 13 | $1,039 | $80 |
| Carvedilol | 69 | $1,029 | $15 |
| Valsartan | 15 | $917 | $61 |
| Omeprazole | 49 | $917 | $19 |
| Spironolactone | 36 | $866 | $24 |
| Rosuvastatin | 46 | $862 | $19 |
| Hydralazine | 30 | $626 | $21 |
| Levothyroxine | 49 | $603 | $12 |
| Tamsulosin | 23 | $578 | $25 |
| Chlorthalidone | 28 | $520 | $19 |
| Famotidine | 18 | $470 | $26 |
| Pantoprazole | 26 | $454 | $17 |
| Metformin Hcl Er | 18 | $367 | $20 |
| Triamterene-Hydrochlorothiazid | 21 | $345 | $16 |
| Prednisone | 33 | $320 | $10 |
| Gabapentin | 25 | $318 | $13 |
| Metformin | 22 | $318 | $14 |
| Hydrochlorothiazide | 76 | $305 | $4 |
| Clonidine | 22 | $289 | $13 |
| Metoprolol | 36 | $272 | $8 |
| Glipizide | 15 | $238 | $16 |
| Simvastatin | 23 | $219 | $10 |
| Alprazolam | 17 | $175 | $10 |
| Acyclovir | 14 | $172 | $12 |
| Zolpidem | 16 | $148 | $9 |
| Escitalopram | 16 | $115 | $7 |
2022: 51 drugs
| Eliquis | 32 | $38,821 | $1,213 |
| Jardiance | 19 | $29,510 | $1,553 |
| Farxiga | 22 | $27,992 | $1,272 |
| Tradjenta | 17 | $25,415 | $1,495 |
| Januvia | 18 | $22,792 | $1,266 |
| Procrit | 24 | $15,890 | $662 |
| Potassium Citrate Er | 58 | $15,023 | $259 |
| Veltassa | 12 | $12,963 | $1,080 |
| Sevelamer Carbonate | 15 | $7,977 | $532 |
| Colchicine | 30 | $6,463 | $215 |
| Lantus | 11 | $4,009 | $364 |
| Calcium Acetate | 39 | $3,396 | $87 |
| Atorvastatin | 208 | $2,933 | $14 |
| Allopurinol | 158 | $2,635 | $17 |
| Metoprolol | 94 | $2,632 | $28 |
| Losartan | 180 | $2,128 | $12 |
| Diltiazem 24hr Er (Cd) | 16 | $1,875 | $117 |
| Furosemide | 145 | $1,424 | $10 |
| Lisinopril | 126 | $1,294 | $10 |
| Amlodipine Besylate | 146 | $1,152 | $8 |
| Synthroid | 12 | $1,140 | $95 |
| Potassium Chloride | 14 | $1,124 | $80 |
| Rosuvastatin | 41 | $1,118 | $27 |
| Carvedilol | 75 | $922 | $12 |
| Chlorthalidone | 24 | $916 | $38 |
| Omeprazole | 46 | $845 | $18 |
| Levothyroxine | 51 | $793 | $16 |
| Valsartan | 13 | $725 | $56 |
| Felodipine Er | 11 | $710 | $65 |
| Prednisone | 37 | $701 | $19 |
| Gabapentin | 30 | $588 | $20 |
| Midodrine | 12 | $524 | $44 |
| Pantoprazole | 32 | $482 | $15 |
| Zolpidem | 16 | $422 | $26 |
| Metformin | 27 | $416 | $15 |
| Tamsulosin | 15 | $399 | $27 |
| Simvastatin | 28 | $394 | $14 |
| Hydralazine | 20 | $345 | $17 |
| Spironolactone | 22 | $336 | $15 |
| Oxycodone | 14 | $323 | $23 |
| Metformin Hcl Er | 16 | $318 | $20 |
| Famotidine | 14 | $289 | $21 |
| Hydrochlorothiazide | 64 | $279 | $4 |
| Triamterene-Hydrochlorothiazid | 17 | $268 | $16 |
| Metoprolol | 47 | $230 | $5 |
| Glipizide | 19 | $215 | $11 |
| Finasteride | 12 | $214 | $18 |
| Alprazolam | 15 | $198 | $13 |
| Acyclovir | 11 | $140 | $13 |
| Ciprofloxacin | 13 | $87 | $7 |
| Clonidine | 20 | $73 | $4 |
2021: 43 drugs
| Januvia | 33 | $38,635 | $1,171 |
| Eliquis | 20 | $24,751 | $1,238 |
| Procrit | 25 | $21,696 | $868 |
| Xarelto | 11 | $17,033 | $1,548 |
| Potassium Citrate Er | 56 | $13,450 | $240 |
| Tradjenta | 11 | $13,062 | $1,187 |
| Retacrit | 24 | $9,950 | $415 |
| Sevelamer Carbonate | 14 | $5,508 | $393 |
| Calcium Acetate | 39 | $4,849 | $124 |
| Atorvastatin | 207 | $3,921 | $19 |
| Colchicine | 25 | $3,862 | $154 |
| Metoprolol | 84 | $2,824 | $34 |
| Allopurinol | 130 | $2,824 | $22 |
| Losartan | 156 | $2,719 | $17 |
| Diltiazem 24hr Er (Cd) | 16 | $2,395 | $150 |
| Rosuvastatin | 37 | $2,225 | $60 |
| Bystolic | 11 | $1,840 | $167 |
| Furosemide | 149 | $1,602 | $11 |
| Levothyroxine | 50 | $1,145 | $23 |
| Amlodipine Besylate | 127 | $1,044 | $8 |
| Midodrine | 18 | $1,012 | $56 |
| Carvedilol | 67 | $1,008 | $15 |
| Omeprazole | 39 | $820 | $21 |
| Lisinopril | 90 | $810 | $9 |
| Chlorthalidone | 14 | $656 | $47 |
| Potassium Chloride | 12 | $615 | $51 |
| Prednisone | 22 | $573 | $26 |
| Hydralazine | 15 | $519 | $35 |
| Glipizide | 35 | $500 | $14 |
| Gabapentin | 21 | $475 | $23 |
| Hydrocodone-Acetaminophen | 26 | $461 | $18 |
| Zolpidem | 16 | $452 | $28 |
| Pantoprazole | 15 | $436 | $29 |
| Warfarin | 12 | $402 | $33 |
| Hydrochlorothiazide | 72 | $366 | $5 |
| Metformin | 33 | $356 | $11 |
| Simvastatin | 28 | $338 | $12 |
| Spironolactone | 17 | $326 | $19 |
| Metoprolol | 41 | $270 | $7 |
| Metformin Hcl Er | 14 | $238 | $17 |
| Lidocaine-Prilocaine | 12 | $181 | $15 |
| Tramadol | 13 | $172 | $13 |
| Triamterene-Hydrochlorothiazid | 11 | $167 | $15 |
2020: 40 drugs
| Procrit | 39 | $38,146 | $978 |
| Eliquis | 26 | $25,729 | $990 |
| Januvia | 20 | $21,405 | $1,070 |
| Xarelto | 13 | $18,612 | $1,432 |
| Tradjenta | 19 | $16,297 | $858 |
| Potassium Citrate Er | 46 | $13,820 | $300 |
| Sevelamer Carbonate | 15 | $8,188 | $546 |
| Veltassa | 15 | $7,630 | $509 |
| Colcrys | 17 | $5,356 | $315 |
| Calcium Acetate | 46 | $5,005 | $109 |
| Atorvastatin | 188 | $3,904 | $21 |
| Metoprolol | 59 | $2,521 | $43 |
| Losartan | 147 | $2,402 | $16 |
| Allopurinol | 118 | $2,160 | $18 |
| Diltiazem 24hr Er (Cd) | 19 | $2,065 | $109 |
| Valsartan | 18 | $1,747 | $97 |
| Levothyroxine | 54 | $1,532 | $28 |
| Rosuvastatin | 23 | $1,173 | $51 |
| Furosemide | 150 | $1,160 | $8 |
| Lisinopril | 100 | $1,107 | $11 |
| Amlodipine Besylate | 106 | $929 | $9 |
| Omeprazole | 34 | $757 | $22 |
| Chlorthalidone | 13 | $662 | $51 |
| Carvedilol | 53 | $648 | $12 |
| Hydralazine | 13 | $627 | $48 |
| Diltiazem 24hr Er | 13 | $625 | $48 |
| Pantoprazole | 14 | $570 | $41 |
| Gabapentin | 22 | $545 | $25 |
| Glipizide | 45 | $543 | $12 |
| Metformin | 33 | $515 | $16 |
| Metoprolol | 47 | $513 | $11 |
| Prednisone | 19 | $501 | $26 |
| Hydrochlorothiazide | 71 | $487 | $7 |
| Simvastatin | 32 | $388 | $12 |
| Hydrocodone-Acetaminophen | 12 | $268 | $22 |
| Warfarin | 11 | $232 | $21 |
| Spironolactone | 16 | $204 | $13 |
| Triamterene-Hydrochlorothiazid | 12 | $190 | $16 |
| Atenolol | 15 | $114 | $8 |
| Diazepam | 14 | $83 | $6 |
2019: 35 drugs
| Procrit | 38 | $35,412 | $932 |
| Eliquis | 14 | $15,993 | $1,142 |
| Xarelto | 12 | $15,160 | $1,263 |
| Potassium Citrate Er | 34 | $9,947 | $293 |
| Sevelamer Carbonate | 12 | $6,905 | $575 |
| Atorvastatin | 169 | $4,156 | $25 |
| Calcium Acetate | 30 | $3,707 | $124 |
| Losartan | 168 | $2,659 | $16 |
| Allopurinol | 102 | $2,639 | $26 |
| Diltiazem 24hr Er (Cd) | 17 | $2,574 | $151 |
| Metoprolol | 50 | $2,111 | $42 |
| Valsartan | 19 | $1,865 | $98 |
| Rosuvastatin | 20 | $1,626 | $81 |
| Levothyroxine | 53 | $1,481 | $28 |
| Lisinopril | 112 | $1,195 | $11 |
| Furosemide | 117 | $1,175 | $10 |
| Omeprazole | 44 | $1,026 | $23 |
| Amlodipine Besylate | 82 | $808 | $10 |
| Gabapentin | 22 | $771 | $35 |
| Carvedilol | 35 | $771 | $22 |
| Glipizide | 48 | $674 | $14 |
| Simvastatin | 55 | $655 | $12 |
| Pantoprazole | 19 | $649 | $34 |
| Prednisone | 25 | $636 | $25 |
| Chlorthalidone | 11 | $564 | $51 |
| Hydrochlorothiazide | 61 | $559 | $9 |
| Metformin | 35 | $542 | $15 |
| Metoprolol | 51 | $477 | $9 |
| Olmesartan Medoxomil | 11 | $345 | $31 |
| Warfarin | 16 | $331 | $21 |
| Triamterene-Hydrochlorothiazid | 17 | $324 | $19 |
| Alprazolam | 14 | $195 | $14 |
| Atenolol | 16 | $155 | $10 |
| Azithromycin | 12 | $89 | $7 |
| Diazepam | 13 | $74 | $6 |
2018: 43 drugs
| Procrit | 13 | $21,000 | $1,615 |
| Januvia | 18 | $18,014 | $1,001 |
| Eliquis | 15 | $17,024 | $1,135 |
| Potassium Citrate Er | 32 | $10,724 | $335 |
| Lyrica | 14 | $5,813 | $415 |
| Atorvastatin | 171 | $5,238 | $31 |
| Metoprolol | 88 | $4,770 | $54 |
| Calcium Acetate | 54 | $4,765 | $88 |
| Colcrys | 11 | $4,216 | $383 |
| Allopurinol | 114 | $3,129 | $27 |
| Levothyroxine | 62 | $2,078 | $34 |
| Losartan | 149 | $1,770 | $12 |
| Clorazepate Dipotassium | 12 | $1,362 | $113 |
| Ventolin Hfa | 12 | $1,314 | $109 |
| Rosuvastatin | 17 | $1,268 | $75 |
| Valsartan | 16 | $1,212 | $76 |
| Lisinopril | 131 | $1,162 | $9 |
| Furosemide | 132 | $1,004 | $8 |
| Amlodipine Besylate | 107 | $976 | $9 |
| Prednisone | 41 | $928 | $23 |
| Omeprazole | 54 | $904 | $17 |
| Metformin | 42 | $704 | $17 |
| Simvastatin | 60 | $637 | $11 |
| Hydralazine | 14 | $629 | $45 |
| Hydrochlorothiazide | 61 | $581 | $10 |
| Metoprolol | 64 | $563 | $9 |
| Hydrocodone-Acetaminophen | 17 | $526 | $31 |
| Pantoprazole | 17 | $502 | $30 |
| Gabapentin | 11 | $476 | $43 |
| Triamterene-Hydrochlorothiazid | 23 | $475 | $21 |
| Glipizide | 42 | $453 | $11 |
| Warfarin | 19 | $436 | $23 |
| Pravastatin | 13 | $326 | $25 |
| Irbesartan | 12 | $321 | $27 |
| Diazepam | 29 | $257 | $9 |
| Clopidogrel | 13 | $252 | $19 |
| Carvedilol | 25 | $242 | $10 |
| Spironolactone | 19 | $226 | $12 |
| Alprazolam | 11 | $207 | $19 |
| Famotidine | 13 | $164 | $13 |
| Ciprofloxacin | 16 | $94 | $6 |
| Atenolol | 11 | $90 | $8 |
| Trazodone | 11 | $61 | $6 |
2017: 49 drugs
| Sensipar | 21 | $65,808 | $3,134 |
| Januvia | 20 | $21,230 | $1,062 |
| Procrit | 17 | $21,083 | $1,240 |
| Eliquis | 14 | $14,033 | $1,002 |
| Potassium Citrate Er | 28 | $12,180 | $435 |
| Xarelto | 12 | $11,254 | $938 |
| Calcium Acetate | 50 | $6,664 | $133 |
| Atorvastatin | 202 | $4,967 | $25 |
| Epogen | 16 | $4,847 | $303 |
| Metoprolol | 72 | $3,844 | $53 |
| Allopurinol | 110 | $3,476 | $32 |
| Levothyroxine | 73 | $2,116 | $29 |
| Losartan | 145 | $1,394 | $10 |
| Valsartan | 28 | $1,328 | $47 |
| Omeprazole | 58 | $1,315 | $23 |
| Clorazepate Dipotassium | 13 | $1,137 | $87 |
| Rosuvastatin | 18 | $1,100 | $61 |
| Amlodipine Besylate | 103 | $985 | $10 |
| Lisinopril | 107 | $900 | $8 |
| Proair Hfa | 13 | $863 | $66 |
| Furosemide | 128 | $856 | $7 |
| Oxycodone-Acetaminophen | 12 | $736 | $61 |
| Prednisone | 39 | $589 | $15 |
| Ventolin Hfa | 11 | $585 | $53 |
| Potassium Chloride | 12 | $570 | $48 |
| Spironolactone | 36 | $570 | $16 |
| Metformin | 40 | $558 | $14 |
| Triamterene-Hydrochlorothiazid | 26 | $545 | $21 |
| Simvastatin | 58 | $504 | $9 |
| Hydrochlorothiazide | 61 | $489 | $8 |
| Hydrocodone-Acetaminophen | 15 | $482 | $32 |
| Warfarin | 22 | $465 | $21 |
| Metoprolol | 72 | $463 | $6 |
| Rizatriptan | 12 | $379 | $32 |
| Glipizide | 38 | $356 | $9 |
| Irbesartan | 13 | $318 | $24 |
| Pravastatin | 17 | $306 | $18 |
| Tramadol | 11 | $290 | $26 |
| Levetiracetam | 11 | $281 | $26 |
| Pantoprazole | 15 | $253 | $17 |
| Carvedilol | 22 | $187 | $8 |
| Diazepam | 32 | $161 | $5 |
| Famotidine | 23 | $145 | $6 |
| Hydralazine | 14 | $140 | $10 |
| Azithromycin | 22 | $127 | $6 |
| Alprazolam | 14 | $109 | $8 |
| Ciprofloxacin | 24 | $101 | $4 |
| Trazodone | 16 | $73 | $5 |
| Zolpidem | 15 | $70 | $5 |
2016: 52 drugs
| Sensipar | 43 | $88,761 | $2,064 |
| Fosrenol | 18 | $39,719 | $2,207 |
| Januvia | 25 | $21,961 | $878 |
| Cyclosporine | 20 | $21,260 | $1,063 |
| Xarelto | 16 | $11,988 | $749 |
| Eliquis | 17 | $11,926 | $702 |
| Calcium Acetate | 56 | $7,976 | $142 |
| Tradjenta | 15 | $7,461 | $497 |
| Potassium Citrate Er | 24 | $7,405 | $309 |
| Procrit | 14 | $5,429 | $388 |
| Atorvastatin | 189 | $4,489 | $24 |
| Metoprolol | 77 | $4,331 | $56 |
| Allopurinol | 109 | $3,310 | $30 |
| Midodrine | 15 | $2,798 | $187 |
| Valsartan | 26 | $2,313 | $89 |
| Omeprazole | 78 | $2,154 | $28 |
| Levothyroxine | 69 | $2,000 | $29 |
| Losartan | 120 | $1,332 | $11 |
| Hydrocodone-Acetaminophen | 25 | $958 | $38 |
| Furosemide | 103 | $891 | $9 |
| Amlodipine Besylate | 92 | $844 | $9 |
| Lisinopril | 84 | $813 | $10 |
| Tamsulosin | 14 | $787 | $56 |
| Spironolactone | 38 | $774 | $20 |
| Verapamil Sr | 12 | $742 | $62 |
| Ventolin Hfa | 14 | $731 | $52 |
| Proair Hfa | 11 | $711 | $65 |
| Metoprolol | 69 | $664 | $10 |
| Pravastatin | 22 | $633 | $29 |
| Simvastatin | 65 | $552 | $8 |
| Triamterene-Hydrochlorothiazid | 26 | $531 | $20 |
| Metformin | 38 | $498 | $13 |
| Acyclovir | 13 | $490 | $38 |
| Clopidogrel | 14 | $472 | $34 |
| Hydrochlorothiazide | 58 | $452 | $8 |
| Pantoprazole | 12 | $438 | $36 |
| Warfarin | 24 | $425 | $18 |
| Irbesartan | 12 | $420 | $35 |
| Fludrocortisone Acetate | 11 | $353 | $32 |
| Ibuprofen | 11 | $347 | $32 |
| Zolpidem | 12 | $347 | $29 |
| Prednisone | 25 | $326 | $13 |
| Glipizide | 28 | $266 | $9 |
| Carvedilol | 23 | $248 | $11 |
| Alprazolam | 17 | $226 | $13 |
| Ciprofloxacin | 26 | $209 | $8 |
| Famotidine | 17 | $204 | $12 |
| Diazepam | 23 | $198 | $9 |
| Sertraline | 13 | $165 | $13 |
| Gabapentin | 14 | $165 | $12 |
| Tramadol | 12 | $161 | $13 |
| Atenolol | 12 | $63 | $5 |
2015: 49 drugs
| Sensipar | 50 | $62,449 | $1,249 |
| Fosrenol | 33 | $48,724 | $1,476 |
| Procrit | 32 | $18,780 | $587 |
| Calcium Acetate | 41 | $8,749 | $213 |
| Januvia | 11 | $8,610 | $783 |
| Xarelto | 15 | $8,524 | $568 |
| Potassium Citrate Er | 19 | $6,459 | $340 |
| Cyclosporine | 13 | $6,454 | $496 |
| Tradjenta | 11 | $6,211 | $565 |
| Atorvastatin | 172 | $3,928 | $23 |
| Metoprolol | 74 | $3,821 | $52 |
| Uloric | 13 | $3,368 | $259 |
| Midodrine | 18 | $3,274 | $182 |
| Levothyroxine | 64 | $2,392 | $37 |
| Omeprazole | 76 | $2,314 | $30 |
| Allopurinol | 93 | $2,291 | $25 |
| Losartan | 129 | $1,587 | $12 |
| Furosemide | 117 | $1,329 | $11 |
| Hydrocodone-Acetaminophen | 47 | $1,301 | $28 |
| Tamsulosin | 26 | $1,177 | $45 |
| Pravastatin | 17 | $881 | $52 |
| Proair Hfa | 14 | $802 | $57 |
| Warfarin | 52 | $750 | $14 |
| Spironolactone | 45 | $749 | $17 |
| Potassium Chloride | 13 | $722 | $56 |
| Chlorthalidone | 15 | $693 | $46 |
| Lisinopril | 80 | $684 | $9 |
| Metformin | 43 | $680 | $16 |
| Metoprolol | 76 | $615 | $8 |
| Simvastatin | 60 | $557 | $9 |
| Amlodipine Besylate | 76 | $553 | $7 |
| Fludrocortisone Acetate | 11 | $538 | $49 |
| Minoxidil | 16 | $522 | $33 |
| Irbesartan | 12 | $520 | $43 |
| Triamterene-Hydrochlorothiazid | 26 | $463 | $18 |
| Zolpidem | 14 | $353 | $25 |
| Prednisone | 20 | $292 | $15 |
| Hydrochlorothiazide | 38 | $271 | $7 |
| Carvedilol | 25 | $266 | $11 |
| Ibuprofen | 17 | $239 | $14 |
| Sumatriptan | 12 | $232 | $19 |
| Glipizide | 28 | $228 | $8 |
| Alprazolam | 18 | $214 | $12 |
| Clopidogrel | 12 | $199 | $17 |
| Diazepam | 25 | $162 | $6 |
| Famotidine | 12 | $142 | $12 |
| Gabapentin | 17 | $135 | $8 |
| Atenolol | 17 | $121 | $7 |
| Ciprofloxacin | 16 | $86 | $5 |
2014: 65 drugs
| Sensipar | 46 | $55,852 | $1,214 |
| Fosrenol | 37 | $44,004 | $1,189 |
| Renvela | 12 | $15,305 | $1,275 |
| Calcium Acetate | 84 | $13,431 | $160 |
| Januvia | 22 | $12,884 | $586 |
| Metoprolol | 121 | $6,831 | $56 |
| Xarelto | 16 | $6,310 | $394 |
| Potassium Citrate Er | 26 | $6,071 | $234 |
| Diovan | 18 | $5,483 | $305 |
| Lantus | 17 | $5,204 | $306 |
| Atorvastatin | 174 | $4,693 | $27 |
| Colcrys | 18 | $4,121 | $229 |
| Humalog | 12 | $3,574 | $298 |
| Pradaxa | 11 | $3,298 | $300 |
| Eplerenone | 14 | $2,793 | $200 |
| Diltiazem 24hr Er | 11 | $2,428 | $221 |
| Levothyroxine | 77 | $2,364 | $31 |
| Benicar | 14 | $2,332 | $167 |
| Losartan | 132 | $2,316 | $18 |
| Omeprazole | 92 | $2,296 | $25 |
| Hydrocodone-Acetaminophen | 52 | $1,869 | $36 |
| Midodrine | 22 | $1,667 | $76 |
| Clonidine | 13 | $1,483 | $114 |
| Allopurinol | 104 | $1,287 | $12 |
| Spironolactone | 54 | $1,113 | $21 |
| Irbesartan | 11 | $1,067 | $97 |
| Furosemide | 111 | $1,059 | $10 |
| Klor-Con 8 | 28 | $1,041 | $37 |
| Lansoprazole | 11 | $969 | $88 |
| Warfarin | 65 | $962 | $15 |
| Diltiazem Er | 13 | $948 | $73 |
| Minoxidil | 23 | $927 | $40 |
| Amlodipine Besylate | 69 | $895 | $13 |
| Tamsulosin | 39 | $861 | $22 |
| Lisinopril | 105 | $829 | $8 |
| Metformin | 53 | $789 | $15 |
| Digox | 11 | $771 | $70 |
| Simvastatin | 78 | $731 | $9 |
| Fludrocortisone Acetate | 13 | $721 | $55 |
| Metoprolol | 78 | $698 | $9 |
| Pravastatin | 13 | $681 | $52 |
| Zolpidem | 33 | $497 | $15 |
| Betamethasone Dipropionate | 12 | $408 | $34 |
| Pantoprazole | 12 | $396 | $33 |
| Glipizide | 42 | $395 | $9 |
| Prednisone | 34 | $376 | $11 |
| Sumatriptan | 14 | $320 | $23 |
| Clotrimazole | 12 | $310 | $26 |
| Cephalexin | 22 | $306 | $14 |
| Escitalopram | 19 | $295 | $16 |
| Potassium Chloride | 14 | $283 | $20 |
| Hydrochlorothiazide | 46 | $282 | $6 |
| Gabapentin | 25 | $263 | $11 |
| Triamterene-Hydrochlorothiazid | 16 | $245 | $15 |
| Fluticasone Propionate | 13 | $242 | $19 |
| Carvedilol | 12 | $239 | $20 |
| Levofloxacin | 11 | $218 | $20 |
| Acyclovir | 13 | $193 | $15 |
| Lamotrigine | 14 | $177 | $13 |
| Ibuprofen | 15 | $168 | $11 |
| Diazepam | 18 | $129 | $7 |
| Hydrocortisone | 14 | $118 | $8 |
| Clonidine | 11 | $107 | $10 |
| Atenolol | 18 | $94 | $5 |
| Ciprofloxacin | 14 | $85 | $6 |
2013: 67 drugs
| Sensipar | 55 | $49,567 | $901 |
| Fosrenol | 39 | $35,012 | $898 |
| Renvela | 35 | $27,177 | $776 |
| Calcium Acetate | 127 | $16,747 | $132 |
| Januvia | 30 | $11,707 | $390 |
| Diovan | 21 | $7,071 | $337 |
| Metoprolol | 122 | $6,371 | $52 |
| Atorvastatin | 178 | $6,110 | $34 |
| Lantus | 17 | $4,544 | $267 |
| Potassium Citrate | 21 | $4,500 | $214 |
| Diltiazem 24hr Cd | 29 | $3,643 | $126 |
| Humalog | 12 | $3,284 | $274 |
| Omeprazole | 110 | $3,198 | $29 |
| Losartan | 135 | $2,904 | $22 |
| Clonidine | 15 | $2,177 | $145 |
| Benicar | 14 | $2,018 | $144 |
| Eplerenone | 14 | $1,989 | $142 |
| Metoprolol | 104 | $1,730 | $17 |
| Levothyroxine | 82 | $1,712 | $21 |
| Diltiazem Er | 29 | $1,462 | $50 |
| Escitalopram | 21 | $1,401 | $67 |
| Amlodipine Besylate | 102 | $1,352 | $13 |
| Furosemide | 141 | $1,304 | $9 |
| Lisinopril | 131 | $1,300 | $10 |
| Allopurinol | 96 | $1,173 | $12 |
| Tamsulosin | 41 | $1,163 | $28 |
| Simvastatin | 98 | $1,162 | $12 |
| Lansoprazole | 13 | $1,157 | $89 |
| Warfarin | 63 | $1,154 | $18 |
| Fludrocortisone Acetate | 30 | $1,120 | $37 |
| Spironolactone | 54 | $1,096 | $20 |
| Minoxidil | 32 | $1,051 | $33 |
| Irbesartan | 12 | $1,032 | $86 |
| Oxybutynin Chloride Er | 11 | $990 | $90 |
| Metformin | 66 | $950 | $14 |
| Hydrocodone-Acetaminophen | 56 | $863 | $15 |
| Klor-Con 8 | 21 | $759 | $36 |
| Hydralazine | 18 | $740 | $41 |
| Pantoprazole | 17 | $654 | $38 |
| Carvedilol | 22 | $649 | $30 |
| Pravastatin | 21 | $607 | $29 |
| Fluticasone Propionate | 23 | $561 | $24 |
| Clopidogrel | 16 | $546 | $34 |
| Verapamil Er | 13 | $544 | $42 |
| Midodrine | 12 | $474 | $40 |
| Glipizide | 45 | $470 | $10 |
| Gabapentin | 48 | $420 | $9 |
| Potassium Chloride | 15 | $351 | $23 |
| Topiramate | 17 | $348 | $20 |
| Prednisone | 49 | $339 | $7 |
| Zolpidem | 35 | $318 | $9 |
| Oxycodone-Acetaminophen | 12 | $295 | $25 |
| Indomethacin | 11 | $290 | $26 |
| Cephalexin | 21 | $287 | $14 |
| Acyclovir | 13 | $278 | $21 |
| Atenolol | 30 | $250 | $8 |
| Ibuprofen | 21 | $250 | $12 |
| Hydrochlorothiazide | 51 | $246 | $5 |
| Polyethylene Glycol 3350 | 11 | $246 | $22 |
| Triamterene-Hctz | 22 | $244 | $11 |
| Clonidine | 15 | $219 | $15 |
| Diazepam | 36 | $196 | $5 |
| Sertraline | 11 | $176 | $16 |
| Azithromycin | 12 | $130 | $11 |
| Ciprofloxacin | 15 | $115 | $8 |
| Alprazolam | 16 | $76 | $5 |
| Vitamin D2 | 15 | $19 | $1 |
Money from drug and device companies
$6 in 2024
| 2024 | 1 | 2 | None | $6 |
| 2023 | 1 | 1 | None | $3 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Travere Therapeutics | None | $6 | 2 payments
|
See all 2 published payments
| Travere Therapeutics | Education · 2024-03-22 | None | $3 |
| Travere Therapeutics | Education · 2024-03-22 | None | $3 |
See earlier years (2023)
2023: $3
| Travere Therapeutics | None | $3 | 1 payment
|
Professional record
- NPI
- 1144395435
- Licence
- CA G20356California G20356: Current · expires 2028-10-31
- Trained
- New York University School of Medicine, 1971 · 55 years ago
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00G203560
- Taxonomy
- Federal specialty code 207RN0300X (207RN0300X)
- Mailing address
- 2100 Webster St., Suite 320, San Francisco, CA, 94115
- NPI first listed
- 2006-11-21
- NPI last updated
- 2022-07-29
- NPI record certified
- 2022-07-29
This is when the NPI record was last certified, not a medical board exam.